Raymond James Maintains Outperform on HealthEquity, Raises Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst C. Gregory Peters maintains an Outperform rating on HealthEquity (NASDAQ:HQY) and raises the price target from $100 to $105.
June 07, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James analyst C. Gregory Peters maintains an Outperform rating on HealthEquity and raises the price target from $100 to $105.
The raised price target and maintained Outperform rating from a reputable analyst at Raymond James is likely to positively impact HealthEquity's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100